JPH1135603A5 - - Google Patents

Info

Publication number
JPH1135603A5
JPH1135603A5 JP1997212714A JP21271497A JPH1135603A5 JP H1135603 A5 JPH1135603 A5 JP H1135603A5 JP 1997212714 A JP1997212714 A JP 1997212714A JP 21271497 A JP21271497 A JP 21271497A JP H1135603 A5 JPH1135603 A5 JP H1135603A5
Authority
JP
Japan
Prior art keywords
heparin
δdihs
fructose
bisphosphate aldolase
sulfated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997212714A
Other languages
English (en)
Japanese (ja)
Other versions
JP4166846B2 (ja
JPH1135603A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP21271497A priority Critical patent/JP4166846B2/ja
Priority claimed from JP21271497A external-priority patent/JP4166846B2/ja
Publication of JPH1135603A publication Critical patent/JPH1135603A/ja
Publication of JPH1135603A5 publication Critical patent/JPH1135603A5/ja
Application granted granted Critical
Publication of JP4166846B2 publication Critical patent/JP4166846B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP21271497A 1997-07-24 1997-07-24 ヘパリン結合担体及びフルクトース−１，６−ビスリン酸アルドラーゼの分離方法 Expired - Fee Related JP4166846B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21271497A JP4166846B2 (ja) 1997-07-24 1997-07-24 ヘパリン結合担体及びフルクトース−１，６−ビスリン酸アルドラーゼの分離方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21271497A JP4166846B2 (ja) 1997-07-24 1997-07-24 ヘパリン結合担体及びフルクトース−１，６−ビスリン酸アルドラーゼの分離方法

Publications (3)

Publication Number Publication Date
JPH1135603A JPH1135603A (ja) 1999-02-09
JPH1135603A5 true JPH1135603A5 (enExample) 2005-05-26
JP4166846B2 JP4166846B2 (ja) 2008-10-15

Family

ID=16627219

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21271497A Expired - Fee Related JP4166846B2 (ja) 1997-07-24 1997-07-24 ヘパリン結合担体及びフルクトース−１，６−ビスリン酸アルドラーゼの分離方法

Country Status (1)

Country Link
JP (1) JP4166846B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4633223B2 (ja) * 1999-03-31 2011-02-16 生化学工業株式会社 血管内皮細胞増殖因子依存性血管内皮細胞増殖の抑制剤
JP4633233B2 (ja) * 2000-06-29 2011-02-16 生化学工業株式会社 クラミジア感染症処置剤
US7687609B2 (en) * 2006-05-19 2010-03-30 National Institute Of Advanced Industrial Science And Technology Galectin-glycosaminoglycan complex and method for controlling galectin activity
CN103157452B (zh) * 2013-03-30 2014-12-31 福州大学 脱硫酸化肝素衍生物亲和色谱材料的制备方法

Similar Documents

Publication Publication Date Title
Maccarana et al. Mode of interaction between platelet factor 4 and heparin
Laurent et al. The molecular-weight-dependence of the anti-coagulant activity of heparin
Linhardt et al. Structure and activity of a unique heparin-derived hexasaccharide.
Rosenberg et al. Correlation between structure and function of heparin
JP5106097B2 (ja) 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出
Seo et al. Preparation, separation, and conformational analysis of differentially sulfated heparin octasaccharide isomers using ion mobility mass spectrometry
Miller et al. A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms
Linhardt et al. Search for the heparin antithrombin III-binding site precursor.
Grant et al. Metachromatic activity of heparin and heparin fragments
EP1580197A1 (en) Method for quantitatively determining specific groups constituting heparins or low molecular wieght heparins using HPLC
Linhardt et al. Low molecular weight dermatan sulfate as an antithrombotic agent structure-activity relationship studies
JP6122418B2 (ja) アンチトロンビンｉｉｉ結合部位を２個含む多糖、これの調製および抗血栓薬剤としてのこれの使用
Yu et al. Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry
Chi et al. Mass spectrometry for the analysis of highly charged sulfated carbohydrates
Kim et al. Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin
Sweeney et al. Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry
Ogamo et al. Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides
Yu et al. Filter-entrapment enrichment pull-down assay for glycosaminoglycan structural characterization and protein interaction
Linhardt et al. New methodologies in heparin structure analysis and the generation of LMW heparins
Stone et al. Structure-function relations of heparin-mimetic sulfated xylan oligosaccharides: inhibition of Human Immunodeficiency Virus-1 infectivity in vitro
US20040265943A1 (en) Method for quantitatively determining specific groups constituting heparins or low molecular weight heparins
JPH1135603A5 (enExample)
Pejler Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin
Scully et al. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation
Danishefsky Synthesis and properties of heparin derivatives